Aileron Therapeutics, Inc.ALRNNASDAQ

52-Week Range2-7

1.61Current 2.117.42

Want to monitor ALRN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

aileron is the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Rivian Shares Rally 8% After Uber Invests Up To $1.25 Billion In Robotaxi Deal

StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach

ALIT DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Alight (ALIT) Investors of Securities Class Action Deadline on May 15, 2026

ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Duolingo (NASDAQ: DUOL)

Darden Restaurants (DRI) Q3 Earnings Match Estimates

These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity

BRBR Investors Have Opportunity to Lead BellRing Brands, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Berger Montague PC Investigating Potential Claims on Behalf of goeasy Ltd. Investors (OTC: EHMEF)

ITWO: Capitalizes On The Rotation Out Of Technology (Rating Upgrade)

MUB: Buying With Conviction

Peet's Coffee Partners with SoundHound AI to Power In-Store Employee Support Across Its Nationwide U.S. Retail Footprint

Jerónimo Martins, SGPS, S.A. (JRONY) Q4 2025 Earnings Call Transcript

Sally Beauty Expands into Social Commerce with Launch on TikTok Shop

Bessent Says US Could Release More Oil From SPR

Xiaomi to invest at least $8.7 billion in AI over next three years, CEO says

Northrop Grumman Announces Date for First Quarter 2026 Financial Results and Webcast

NextTrip Strengthens Global Media Leadership as JOURNY Streaming Network Expands

Time for NVIDIA-Heavy ETFs?

SCHD: Winning The Rotation Trade With High-Quality Yield

Alibaba: Ignore The Market Panic, It Was An OK Quarter (Rating Downgrade)

About